Anti-Human CD40 (Clone HB-14) – Purified in vivo GOLDTM Functional Grade

Anti-Human CD40 (Clone HB-14) – Purified in vivo GOLDTM Functional Grade

Product No.: C1030

- -
- -
Clone
HB-14
Target
CD40
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
BP50, TNFRSF5, CDW40
Isotype
Mouse IgG1 κ
Applications
FA
,
FC
,
IHC

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Mouse
Recommended Dilution Buffer
Immunogen
Recombinant protein of CD40 protein
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
≤ 1.0 EU/mg as determined by the LAL method
Purity
≥95% by SDS Page
≥95% monomer by analytical SEC
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8°C Wet Ice
Additional Applications Reported In Literature ?
FA,
IHC,
FC
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone HB-14 recognizes human CD40.
Background
CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40, in association with its ligand CD154 (CD40L) - a 39 kD protein, acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other antigen-presenting cells. CD40 is involved in Ig isotype switching and dendritic cell maturation, as well as the activation, differentiation, and proliferation of B cells. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy; blocking the interaction of CD40 with its ligand (CD154) is the sought-after therapeutic objective for preventing and/or improving both autoimmune diseases and transplant rejection. Studies have shown that monoclonal antibodies that block CD154 in human clinical trials resulted in unanticipated vascular complications. Hence, an interest in the therapeutic potential for antagonist mAbs specific to human CD40 is emerging. Antibodies of particular therapeutic interest are those that do not inhibit CD40 signaling via physical competition with CD154. Additionally, the interaction of CD40 and its ligand (CD154) is found to be essential for amyloid-beta-induced microglial activation, thus playing a significant part in Alzheimer's disease pathogenesis.

The anti-CD40 HB-14 clone was generated as part of a panel submitted to the Fifth International Leukocyte Differentiation Antigen Workshop1.
Antigen Distribution
CD40 is widely expressed on antigen-presenting cells such as dendritic cells, B cells, macrophages, and monocytes, in addition to non-immune endothelial cells, basal epithelial cells, and a variety of tumors.
Ligand/Receptor
CD154 (CD40 ligand)
NCBI Gene Bank ID
UniProt.org
Research Area
Cell Biology
.
Costimulatory Molecules
.
Immunology
.
Neuroscience

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

The antibody HB-14 (clone name) is an anti-CD40 monoclonal antibody widely used in in vivo mouse studies to modulate immune responses. CD40 is a costimulatory protein found mainly on antigen-presenting cells, and engaging or blocking this molecule can profoundly affect immune function.

In vivo Uses of Clone HB-14:

  • Activation or Blockade of CD40: In mouse models, HB-14 is used to activate or block the CD40 receptor on dendritic cells and other antigen-presenting cells, thus influencing T cell-dependent immune responses.
  • Study of Immune Pathways: It is applied to investigate the role of CD40-mediated signaling pathways, including their effects on dendritic cell maturation, cytokine production, B cell help, and immune regulation.
  • Phenotype Analysis: This antibody has also been used for ex vivo and in vivo characterization of immune cell populations by flow cytometry, particularly for dendritic cell (DC) phenotype analysis.

Experimental Applications:

  • Flow Cytometry: To identify and analyze CD40+ cells within various tissues or blood of mice after treatment or in disease models.
  • Immune Modulation: Administration of HB-14 in mice (by injection) to enhance or inhibit immune reactions in cancer models, transplantation, or during infection, usually by targeting CD40-expressing cells.

Typical Protocols and Considerations:

  • The antibody can be injected intraperitoneally or intravenously, but the optimal dosing and frequency depend on the experiment's goal and must be determined experimentally.
  • HB-14 can be used as a functional-grade antibody, meaning it is suitable for use in live animal experiments without causing unwanted effector functions due to its Fc region modifications or isotype selection.
  • Effects on immune modulation can include enhanced antigen presentation, T cell priming, and/or B cell activation, depending on whether the antibody acts as an agonist (activates CD40 signaling) or antagonist (blocks ligand binding).

Summary Table: HB-14 in Mouse Studies

ApplicationMethodExperimental Goal
Immune activation/blockadeIn vivo injectionModulate antigen presentation or T cell responses
Phenotype/cell analysisFlow cytometry (ex vivo)Identify and quantify CD40+ cells

For individual protocols and recommended dilutions or dosing, consult the antibody datasheet or primary research articles using HB-14.

Note: If you meant a different HB-14 (not anti-CD40), please specify the target antigen or context for clarification. Different antibodies and clones may share similar nomenclature. The above details are based on anti-CD40 [HB-14] as listed in the provided sources.

To determine the correct storage temperature for the sterile packaged clone HB-14, we would need specific information about the product itself, such as its composition or intended use. However, based on common practices for storing biological materials and sterile products, here are some general guidelines:

  1. General Storage for Biological Reagents: Many biological reagents, including some types of clones, are typically stored at freezer temperatures (e.g., -20°C or -80°C) to maintain stability and prevent degradation. However, specific storage temperatures can vary based on the product's formulation and stability characteristics.

  2. Reference to QIAprep Miniprep Kits: These kits are stored dry at room temperature (15–25°C) for up to 12 months but can also be stored at 2–8°C for longer periods or special conditions.

  3. Vaccine Storage: Vaccines, like RECOMBIVAX HB or GARDASIL 9, are stored refrigerated at 2°C to 8°C to maintain potency.

Without specific details about the clone HB-14, it is difficult to provide precise storage instructions. Typically, if the product is a biological clone (e.g., a genetic material), it might be stored frozen to preserve integrity, but this would depend on the clone's characteristics and handling guidelines.

For precise storage conditions, refer to the product documentation or contact the manufacturer or supplier for specific guidance.

Commonly used antibodies and proteins with HB-14 (anti-human CD40 antibody) in the literature typically include those targeting B cell markers, activation molecules, and cytokines, as well as reagents for costimulatory cell signaling and immune cell characterization.

Key antibodies/proteins frequently used with HB-14 in experimental setups include:

  • Anti-IgM: Frequently combined with HB-14 to promote B cell proliferation or activation, highlighting co-stimulation mechanisms.
  • Interleukin-4 (IL-4): Often used alongside HB-14 to support B cell proliferation and differentiation tasks.
  • Phorbol 12-myristate 13-acetate (PMA): Utilized in combination with HB-14 for robust B cell activation studies.
  • TLR ligands (e.g., CpG, LPS): Used to stimulate regulatory B10 cell production or immune responses in conjunction with HB-14, particularly for studying cytokine secretion such as IL-10.
  • CD40L (CD154): As the natural ligand for CD40, it is central in studies examining HB-14-mediated signaling, cell-to-cell interactions, and rescue from apoptosis.
  • Other B cell surface markers (such as CD19, CD20, or CD86): These are commonly used in multicolor flow cytometry panels with HB-14 to distinguish B cell subsets or activation states.

Associated reagents may also include:

  • Endotoxin-free buffers and azide-free formulations, necessary for cell culture and functional assays using HB-14.
  • Various fluorochrome-conjugated HB-14 formats (e.g., FITC, PE, APC), allowing multiplex analysis with other antibodies targeting distinct cell markers.

The literature routinely references combinations of HB-14 with anti-IgM, cytokines (e.g., IL-4), and TLR agonists, indicating their roles in dissecting B cell regulation, costimulation, and differentiation pathways in immunology research.

The search results do not contain specific key findings from clone HB-14 citations in scientific literature. The mention of clone HB-14 appears in the context of a scientific publication without providing details about the clone itself or its findings. If you are looking for specific research or findings related to clone HB-14, you may need to access the full text of the relevant publication or search through broader scientific databases like PubMed or Google Scholar. However, here are some related areas of research:

Related Research Areas

  1. Immunology and Cell Biology: Research involving clones like HB-14 often focuses on understanding cell biology mechanisms, which can include studies on cell signaling, gene expression, or immune responses.

  2. Base Editing and Gene Regulation: Recent studies have explored the use of base editing to modify gene regulation, particularly in the context of globin gene expression and fetal hemoglobin (HbF) induction.

  3. BCL11A and Hemoglobinopathies: The role of BCL11A in regulating ?-globin and its potential as a therapeutic target for hemoglobinopathies is an active area of research.

Without specific details on clone HB-14, it is challenging to pinpoint key findings directly related to this clone. If you have more context or details, further targeted searches might yield more relevant results.

References & Citations

1. Katira A, Holder MJ, Pound JD, and Gordon J. 1995. CD40 Workshop Panel Report. In Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, and Todd RF, eds, Leukocyte Typing V, p. 547. Oxford University Press, Oxford.
2. Herbert J. Thesis: The regulation of specific antibody secretion by human B cells through contact and non-contact dependent mechanisms. 1996. https://discovery.ucl.ac.uk/id/eprint/10100666/1/out.pdf
3. Zhou LJ, Tedder TF. Proc Natl Acad Sci U S A. 93(6):2588-2592. 1996.
4. Tan PH, Beutelspacher SC, Xue SA, et al. Blood. 105(10):3824-3832. 2005.
5. Iwata Y, Matsushita T, Horikawa M, et al. Blood. 117(2):530-541. 2011.
6. Bacher P, Schink C, Teutschbein J, et al. J Immunol. 190(8):3967-3976. 2013.
7. Bacher P, Heinrich F, Stervbo U, et al. Cell. 167(4):1067-1078.e16. 2016.
8. Mura M, Chaudhury S, Farooq F, et al. MethodsX. 22;7:101005. 2020.
9. Pound JD, Challa A, Holder MJ, et al. Int Immunol. 11(1):11-20. 1999.
FA
Flow Cytometry
IHC

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.